Tagged with M

IFPMA On Universal Health Coverage day, the Director General of IFPMA (the International Federation of Pharmaceutical Manufacturers and Associations) explains UHC and how the biopharmaceutical industry is part of the solution.   Our industry is much more than a supplier of medicines and vaccines and is increasingly pioneering new ways to overcome…

Turkey Levent Canyurt, CEO and founder of BIEM Ilac, shares how he transformed the company from a domestic pharmaceutical distributor into an international player, with an innovative portfolio for the treatment of rare diseases. He also highlights the importance of greater collaboration between stakeholders in the Turkish biotech industry and gives…

Turkey Mehmet Baharoglu and Beril Tezcanli of Birgi Mefar Group, Turkey’s leading CMO with a proven track record and experience of production across all small and medium volume injectable dosage forms for local, international and multinational pharmaceuticals, provide insights into the Group’s unrivalled expertise and competitive advantages as well as its…

Korea Roger Zbinden, head of the Swiss Business Hub Korea, explains their efforts to raise the profile of the South Korean market for Swiss business. Dr Zbinden also provides his insights into opportunities that exist in the Korean market and explains why Korea need not follow the Swiss model in its…

USA David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the venture investment activity in life sciences for the past year.    In order to have a successful life sciences R&D program, biotech and pharma companies must develop game-changing therapeutics, companion diagnostics and personalized…

France INCa – Institut National du Cancer (The National Cancer Institute)       The National Cancer Institute (INCa) is the state agency of health and scientific expertise in oncology in charge of coordinating actions to fight against cancer. Created by the public health law of August 9, 2004, it is placed…

France DSS Direction de la Sécurité (Department of Social Security)   Key People: Director General Mathilde Lignot-Leloup The Directorate of Social Security (DSS) supervises all social security organizations: general scheme funds, basic scheme funds of independent professions other than agricultural, or special schemes funds. It also participates in the supervision of complementary…

France Commission des Affaires Sociales de l’Assemblée Nationale (Commission of Social Affairs, National Assembly)   Key People: Brigitte Bourguignon, Chairwoman Olivier Véran, General Reporter The Social Affairs Committee of the National Assembly is one of the eight standing committees of the French National Assembly. The areas of competence of the Social Affairs Committee are…

France Joël Jaouen, president of France Alzheimer, provides important insights into the role and objectives of the patient association. He explains why France Alzheimer together with other learned societies filed a case with the State Council against the French Minister of Health & Solidarity.   Alzheimer’s scares. Why? Because it is…

Turkey Barış Özyurtlu, general manager of Berko Pharmaceuticals, one of the fastest growing companies in Turkey, provides insights into the company’s innovative vision and proprietary technologies, such as its spoon-shaped product presentation. The latter has already caught the attention of several partners in the US and Canada and should further propel…

France Lundbeck France and Benelux’s Lourdes Pla discusses Europe-wide restructuring, the importance of the French affiliate to the global group and the government’s attitude towards healthcare and neuroscience.   We are the only specialty pharma player exclusively dedicated to neuroscience and it is important that this shines through in our dealings…

IFPMA Geneva, 4 December 2018 – David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company, was elected new President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) for a two-year term. He succeeds Ian C. Read, Chairman of the Board and Chief Executive Officer, Pfizer. The IFPMA…